22 July 2025
A National Patient Safety Alert (NatPSA/2025/003/DHS) was issued on 03 Jul 2025 relating to the shortage of Bumetanide 1mg tablets. The alert provides clinical guidance and outlines mandatory actions that must be implemented to ensure patient safety during the disruption period. All actions are to be completed by 11 July 2025 and to remain in place only until the supply issues have resolved (see Medicine Supply Tool for up to date resolution dates).
Key Information:
- Bumetanide 1mg tablets: Out of stock until the anticipated re-supply date of 15 August 2025
- Bumetanide 1mg/5ml oral solution and 5mg tablets: Remain available but cannot support increased demand
- Furosemide 20mg and 40mg tablets: Remain available and can support increased demand
Actions for all Prescribers - deadline 11th July 2025:
- Please refer to National Patient Safety Alert (NatPSA/2025/003/DHSC); review the outlined actions and ensure appropriate implementation.